Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Invest Dermatol. 2013 Nov 8;134(4):1143–1145. doi: 10.1038/jid.2013.472

Figure 1.

Figure 1

In vitro effects of SEI003 and aprotinin on KLK and human total stratum corneum protease activity. (A) Both SEI003 and aprotinin inhibit KLK activity compared to vehicle alone. SEI003 completely blocks KLK activity for the first 45 minutes of the assay. (B) Compared to vehicle alone, SEI003 and aprotinin both significantly decrease stratum corneum protease activity.